Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma
Pediatric Blood & Cancer · 2023
DOI: 10.1002/pbc.30421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Friedrich Christian Franke und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Diakoniekrankenhaus Halle, Halle (Saale), Germany. Hauptthemen laut MEDLINE: Hodgkin Disease, Thymus Hyperplasia, Lymphoma, Thymus Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Rebound thymic hyperplasia (RTH) is a common phenomenon caused by stress factors such as chemotherapy (CTX) or radiotherapy, with an incidence between 44% and 67.7% in pediatric lymphoma. Misinterpretation of RTH and thymic lymphoma relapse (LR) may lead to unnecessary diagnostic procedures including invasive biopsies or treatment intensification. The aim of this study was to identify parameters that differentiate between RTH and thymic LR in the anterior mediastinum.
Methods
After completion of CTX, we analyzed computed tomographies (CTs) and magnetic resonance images (MRIs) of 291 patients with classical Hodgkin lymphoma (CHL) and adequate imaging available from the European Network for Pediatric Hodgkin lymphoma C1 trial. In all patients with biopsy‐proven LR, an additional fluorodeoxyglucose (FDG)‐positron emission tomography (PET)‐CT was assessed. Structure and morphologic configuration in addition to calcifications and presence of multiple masses in the thymic region and signs of extrathymic LR were evaluated.
Results
After CTX, a significant volume increase of new or growing masses in the thymic space occurred in 133 of 291 patients. Without biopsy, only 98 patients could be identified as RTH or LR. No single finding related to thymic regrowth allowed differentiation between RTH and LR. However, the vast majority of cases with thymic LR presented with additional increasing tumor masses (33/34). All RTH patients (64/64) presented with isolated thymic growth.
Conclusion
Isolated thymic LR is very uncommon. CHL relapse should be suspected when increasing tumor masses are present in distant sites outside of the thymic area. Conversely, if regrowth of lymphoma in other sites can be excluded, isolated thymic mass after CTX likely represents RTH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Diakoniekrankenhaus Halle, Halle (Saale), Germany.
- Department of Radiology, University Hospital Halle (Saale), Halle (Saale), Germany.
- Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
- Institute of Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.
- Department of Pediatric Hematology and Oncology, Justus-Liebig University, Gießen, Germany.
- Sorbonne Université/APHP hôpital Trousseau, Paris, France.
ORCID-Profile: Lars Kurch, Michaela Cepelova, Andishe Attarbaschi, Dietrich Stoevesandt
Zitieren
APA
Franke, F. C., Damek, A., Steglich, J., Kurch, L., Hasenclever, D., Georgi, T. W., Wohlgemuth, W. A., Mauz-Körholz, C., Körholz, D., Kluge, R., Landman-Parker, J., Wallace, W. H., Fosså, A., Vordermark, D., Karlen, J., Fernández-Teijeiro, A., Cepelova, M., Klekawka, T., Attarbaschi, A., …, & Stoevesandt, D. (2023). Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30421
Vancouver
Franke FC, Damek A, Steglich J, Kurch L, Hasenclever D, Georgi TW, et al. Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30421
BibTeX
@article{Franke2023,
author = {Franke, Friedrich Christian and Damek, Adrian and Steglich, Jonas and Kurch, Lars and Hasenclever, Dirk and Georgi, Thomas W and Wohlgemuth, Walther Alexander and Mauz-Körholz, Christine and Körholz, Dieter and Kluge, Regine and Landman-Parker, Judith and Wallace, William Hamish and Fosså, Alexander and Vordermark, Dirk and Karlen, Jonas and Fernández-Teijeiro, Ana and Cepelova, Michaela and Klekawka, Tomasz and Attarbaschi, Andishe and Ceppi, Francesco and Hraskova, Andrea and Uyttebroeck, Anne and Beishuizen, Auke and Dieckmann, Karin and Leblanc, Thierry and Moellers, Martin and Buerke, Boris and Stoevesandt, Dietrich},
title = {Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma},
journal = {Pediatric Blood & Cancer},
year = {2023},
doi = {10.1002/pbc.30421}
}
EUVIMED